Aging brains may be vulnerable to a chemical change so small that it can be measured at the level of individual protein building blocks, yet powerful enough to reorganize the interior of neurons. A study by Vignane, Hugo, Hoffmann and colleagues, published in Nature Structural & Molecular Biology, identifies alterations to protein thiols as a potential driver of pathological liquid–liquid phase separation in the aging brain. The work focuses on a biological phenomenon that has transformed scientists’ understanding of how cells organize their molecular machinery. Instead of enclosing every process inside a membrane, cells can gather selected proteins and nucleic acids into temporary, droplet-like compartments known as biomolecular condensates. When this organization is properly regulated, it helps neurons respond rapidly to stress and manage essential reactions. When regulation fails, however, the same physical process may produce persistent assemblies linked to neurodegeneration.
Liquid–liquid phase separation, or LLPS, occurs when molecules in a crowded cellular environment separate into a dense phase and a surrounding dilute phase, much as oil droplets form within water. In cells, weak and reversible interactions among proteins, RNA and other molecules can create condensates that behave like microscopic liquid droplets. These structures can fuse, dissolve, flow and exchange components with their surroundings. Their formation depends on factors including protein concentration, temperature, salt levels, molecular crowding and the presence of chemical modifications. Neurons rely on this dynamic behavior in structures such as stress granules and RNA-processing compartments. The new research places protein thiols at the center of this process, suggesting that changes in these chemically reactive groups can shift condensates from short-lived and functional states toward more stable, disease-associated assemblies.
A thiol is a chemical group containing a sulfur atom bonded to hydrogen, commonly represented as –SH. In biology, thiols are found most prominently in the amino acid cysteine, which is embedded within thousands of proteins. These groups are unusually sensitive to the cell’s redox environment, meaning the balance between reducing and oxidizing chemical conditions. Thiols can undergo oxidation, form disulfide bonds with other cysteine residues, or react with metabolites and oxidized lipids. Such changes can alter a protein’s shape, charge, flexibility, solubility and ability to interact with neighboring molecules. In a young and healthy cell, many thiol modifications are reversible and carefully controlled. With aging, rising oxidative stress, impaired metabolism and declining repair systems can increase the likelihood that these modifications accumulate or persist.
The brain may be especially susceptible because neurons consume large amounts of oxygen, possess extensive and highly branched structures, and generally remain in place for an entire lifetime. Their long axons and dendrites must maintain protein quality over decades, while their membranes contain lipids that can generate reactive by-products when damaged. At the same time, neurons have limited capacity to dilute damaged proteins through cell division. These conditions create an environment in which even modest shifts in protein chemistry can have broad consequences. By changing the behavior of cysteine-containing proteins, thiol alterations could increase the tendency of molecules to cluster, expose previously hidden interaction surfaces or reduce the solubility that normally keeps proteins dispersed. The resulting molecular crowding may favor the nucleation and growth of condensates that no longer dissolve efficiently.
The significance of the study lies in connecting redox biology with the physical chemistry of phase separation. Protein condensation is not controlled only by genetic sequence or protein abundance; it is also influenced by the chemical state of individual residues. A cysteine that is reduced, oxidized, or linked to another molecule can change the network of weak interactions that holds a condensate together. In practical terms, a redox modification may act like a molecular switch, altering the threshold at which proteins begin to separate from the surrounding cellular fluid. If the modification is reversible, a condensate may remain responsive to changing conditions. If it becomes extensive or is combined with other age-related damage, the material can become more viscous, less mobile and increasingly resistant to clearance. Over time, a functional liquid compartment may progress toward a pathological, gel-like or solidified aggregate.
This distinction between healthy and pathological condensates is crucial. Many neuronal condensates are beneficial precisely because they are temporary. During cellular stress, they can concentrate messenger RNA and regulatory proteins, allowing the cell to pause translation and prioritize repair. Once the stress passes, the condensate should disassemble and release its components. A failure to dissolve can trap RNA, enzymes and signaling factors, disrupting protein production and weakening the neuron’s response to further damage. Persistent condensates may also provide a platform where misfolded proteins encounter one another, increasing the risk of fibril formation and larger aggregates. The study’s central implication is therefore not that phase separation itself is harmful, but that age-related thiol chemistry may push a normally adaptive process beyond its safe operating range.
The findings also offer a possible explanation for why oxidative stress and protein aggregation so often appear together in aging and neurodegenerative disease. Oxidation is frequently described as indiscriminate molecular damage, but thiol chemistry suggests a more nuanced mechanism. Reactive oxygen and nitrogen species can modify selected cysteine residues, while changes in cellular metabolism can influence the availability of reducing agents that normally restore them. These chemical events may remodel protein interaction networks before visible aggregates appear. In this model, altered thiols could serve as an early molecular trigger, phase separation could amplify the disturbance, and prolonged condensation could create conditions that favor irreversible aggregation. That sequence would help bridge two major areas of neuroscience: the study of redox imbalance and the study of aberrant protein assemblies.
The research may also point toward new ways of detecting or treating age-related brain disorders. If particular thiol modifications mark the transition from physiological to pathological condensation, they could become molecular biomarkers of early neuronal stress. Therapeutic strategies might aim to restore redox balance, protect vulnerable cysteine residues, regulate enzymes that add or remove thiol modifications, or tune the physical properties of condensates themselves. Such approaches would need to be highly selective. Broadly suppressing oxidation could interfere with normal signaling, because controlled cysteine oxidation is also used by cells to regulate enzymes and stress responses. Likewise, blocking all phase separation would be impossible and undesirable, since condensates are fundamental to gene regulation, RNA metabolism and cellular organization. The challenge will be to identify the specific chemical changes and condensate states that distinguish protective adaptation from pathological persistence.
The study’s broader message is that brain aging may be governed not only by the accumulation of damaged proteins, but also by changes in how proteins organize themselves before damage becomes visible. A single thiol alteration does not automatically create a disease process, and the relationship between redox chemistry, phase separation and neurodegeneration will require further testing across cell types, brain regions and stages of aging. Nevertheless, the work highlights a striking biological possibility: the aging brain may gradually lose control over the material state of its proteins. As cellular chemistry shifts, molecules that once assembled and dispersed on demand can become trapped in abnormal droplets, creating a self-reinforcing environment of stress and aggregation. By linking cysteine reactivity to the physics of biomolecular condensation, Vignane and colleagues provide a new framework for understanding how microscopic chemical changes can produce macroscopic consequences for the aging nervous system.
Subject of Research: Protein thiol alterations and pathological liquid–liquid phase separation in the aging brain
Article Title: Protein thiol alterations drive pathologic liquid–liquid phase separation in the aging brain
Article References: Vignane, T., Hugo, M., Hoffmann, C. et al. “Protein thiol alterations drive pathologic liquid–liquid phase separation in the aging brain.” Nature Structural & Molecular Biology 33, 1252–1265 (2026). https://doi.org/10.1038/s41594-026-01857-w
Image Credits: AI Generated
DOI: 10.1038/s41594-026-01857-w
Keywords: aging brain, protein thiols, cysteine oxidation, redox biology, liquid–liquid phase separation, biomolecular condensates, oxidative stress, neurodegeneration, protein aggregation
Tags: aging-related changes in neuronal protein chemistrybiomolecular condensates in neuronal cellscellular compartmentalization without membraneseffects of aging on protein-protein interactionsimpact of protein phase separation on brain healthliquid-liquid phase separation and neurodegenerationmolecular mechanisms of liquid-liquid phase separationneurodegenerative disease linked to phase separationprotein aggregation and neuronal stress responseprotein modifications and cell organizationprotein thiol alterations in aging brainrole of protein thiols in cellular phase transitions
